Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer.
about
Patient considerations in metastatic colorectal cancer - role of panitumumab.EPMA position paper in cancer: current overview and future perspectives.An immunohistochemical study of EGFR expression in colorectal cancer and its correlation with lymph nodes status and tumor grade.A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11.
P2860
Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Efficacy of the monoclonal ant ...... metastatic colorectal cancer.
@ast
Efficacy of the monoclonal ant ...... metastatic colorectal cancer.
@en
type
label
Efficacy of the monoclonal ant ...... metastatic colorectal cancer.
@ast
Efficacy of the monoclonal ant ...... metastatic colorectal cancer.
@en
prefLabel
Efficacy of the monoclonal ant ...... metastatic colorectal cancer.
@ast
Efficacy of the monoclonal ant ...... metastatic colorectal cancer.
@en
P2860
P356
P1433
P1476
Efficacy of the monoclonal ant ...... f metastatic colorectal cancer
@en
P2860
P356
10.3747/CO.V17IS1.616
P478
17 Suppl 1
P577
2010-07-01T00:00:00Z